Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
| Actual shortage: | 217 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2017-03-10 | 2018-01-31 | 18 |
| APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2021-06-25 | 2021-07-26 | 141515 |
| APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2018-03-05 | 2018-05-24 | 41838 |
| APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2021-09-17 | 2021-09-27 | 145818 |
| APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2020-06-17 | 2020-07-28 | 118040 |
| APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2019-07-17 | 2019-08-30 | 89570 |
| APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2017-03-10 | 2017-04-21 | 21 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Resolved | 2020-07-23 | 2020-09-01 | 120964 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Actual shortage | 2025-03-13 | 2025-05-01 | 252560 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Actual shortage | 2024-12-19 | 2025-05-01 | 246067 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Resolved | 2020-01-08 | 2020-02-19 | 102523 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Resolved | 2021-11-26 | 2021-12-23 | 150052 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2019-06-12 | 2019-07-12 | 86271 |
| APO-ALENDRONATE | 5MG | TABLET | Resolved | 2017-10-11 | 2018-03-27 | 25204 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2022-07-11 | 2022-08-11 | 164370 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2018-08-27 | 2018-11-26 | 59284 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2021-11-22 | 2021-12-01 | 149699 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2017-03-11 | 2017-06-05 | 633 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2018-05-15 | 2018-07-03 | 49415 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2022-06-06 | 2022-08-11 | 162080 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |